A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Baricitinib
Related studies linked through entity extraction aliases.
Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male Subjects
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
JAK Inhibitor Treatment in AGS
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Baricitinib Treatment on Peripheral Bone in RA
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Status
- RECRUITING
- Phase
- PHASE3
Molecular Signatures in Inflammatory Skin Disease
- Status
- RECRUITING
- Phase
- N/A
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3